Retatrutide, a newer triple agonist in development, targets GLP-1, GIP, and glucagon receptors
Additionally, individuals with eating disorders, body dysmorphic disorder, or unrealistic weight loss expectations may experience psychological distress during treatment that could manifest as depressive symptoms or suicidal thoughts
Knowing how to respond allows you to address problems quickly and decide whether to continue, modify, or discontinue copper peptide use
Related sexual health treatments Different approaches for different needs
Jardiance has fewer gastrointestinal side effects compared to Mounjaro, while Mounjaro may reduce the efficacy of oral hormonal contraceptives due to delayed gastric emptying